↓ Skip to main content

Dove Medical Press

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

Overview of attention for article published in International Journal of Nanomedicine, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
17 Mendeley
Title
Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice
Published in
International Journal of Nanomedicine, September 2022
DOI 10.2147/ijn.s359114
Pubmed ID
Authors

Muhammed A Saad, Noha M Eissa, Mohammed A Ahmed, Aliaa N ElMeshad, Götz Laible, Ahmed S Attia, Medhat A Al-Ghobashy, Rania M Abdelsalam, Muhammad Y Al-Shorbagy

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 4 24%
Student > Master 2 12%
Student > Bachelor 1 6%
Student > Doctoral Student 1 6%
Student > Ph. D. Student 1 6%
Other 0 0%
Unknown 8 47%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 29%
Agricultural and Biological Sciences 2 12%
Neuroscience 1 6%
Medicine and Dentistry 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2022.
All research outputs
#8,544,090
of 25,392,582 outputs
Outputs from International Journal of Nanomedicine
#1,080
of 4,122 outputs
Outputs of similar age
#154,034
of 429,605 outputs
Outputs of similar age from International Journal of Nanomedicine
#11
of 81 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,122 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.